drug

INKmune

Phase 2updated 3mo ago

by $INMB Inmune Bio, Inc.

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying INKmune

phase1A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AMLterminatedn=2
phase2Study of INKmune in Patients With mCRPC (CaRe Prostate)completedn=12

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 42m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

INKmune

Phase 2updated 3mo ago

by $INMB Inmune Bio, Inc.

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying INKmune

phase1A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AMLterminatedn=2
phase2Study of INKmune in Patients With mCRPC (CaRe Prostate)completedn=12

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 42m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

INKmune

all catalysts(0)

Trials studying INKmune

News(0)

Report a data issue

comments(0)

INKmune

all catalysts(0)

Trials studying INKmune

News(0)

Report a data issue

comments(0)